STOCK TITAN

Cell Source Stock Price, News & Analysis

CLCS OTC Link

Company Description

Welcome to the overview page for Cell Source (CLCS), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
+220%
Performance 1 year
$21.2M

SEC Filings

No SEC filings available for Cell Source.

Financial Highlights

-$5.3M
Net Income (TTM)
-$2.3M
Operating Cash Flow
Revenue (TTM)

Upcoming Events

JUN
17
June 17, 2026 Financial

Convertible notes maturity

OID convertible notes due earlier of 2026-06-17 or Nasdaq listing; $1.875M principal; 10% interest

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Cell Source (CLCS) currently stands at 11.7 thousand shares, up 80.7% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 131.2%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Cell Source (CLCS) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1.6 days.

Frequently Asked Questions

What is the current stock price of Cell Source (CLCS)?

The current stock price of Cell Source (CLCS) is $0.96 as of February 27, 2026.

What is the market cap of Cell Source (CLCS)?

The market cap of Cell Source (CLCS) is approximately 21.2M. Learn more about what market capitalization means .

What is the net income of Cell Source (CLCS)?

The trailing twelve months (TTM) net income of Cell Source (CLCS) is -$5.3M.

What is the earnings per share (EPS) of Cell Source (CLCS)?

The diluted earnings per share (EPS) of Cell Source (CLCS) is $-0.17 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Cell Source (CLCS)?

The operating cash flow of Cell Source (CLCS) is -$2.3M. Learn about cash flow.

What is the operating income of Cell Source (CLCS)?

The operating income of Cell Source (CLCS) is -$4.3M. Learn about operating income.